Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd, is a precision medicine company that develops diagnostic solutions for cancer and other diseases. The company offers products such as FoundationOne CDx, a tissue-based test for solid tumors; FoundationOne Liquid CDx, a blood-based test for solid tumors; FoundationOne Heme, a test for hematologic malignancies and solid tumors and FoundationOne PGx. Foundation Medicine also offers immunohistochemistry testing and germline testing. The company provides biopharma services, including discovery and translational research, clinical development and CDx and access and commercialization services. The company operates in the US and Germany. Foundation Medicine is headquartered in Cambridge, Massachusetts, the US.
Headquarters
United States of America
Address
400 Summer Street, Boston, Massachusetts, 02210
Website
www.foundationmedicine.com
Telephone
1 617 4182200
Industry
Medical Equipment
Foundation Medicine Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Comprehensive Genomic Profiling (CGP) Tests: | Biopharma | FoundationOne |
| FoundationOne CDx: Solid Tumors | Discovery and Translational Research | |
| FoundationOne Liquid CDx: Solid Tumors | Clinical Development and CDx Services | |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
Competitor Comparison
| Key Parameters | Foundation Medicine Inc | Insight Molecular Diagnostics Inc | 20/20 BioLabs | BioReference Health LLC |
|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America |
| City | Boston | Nashville | Rockville | Elmwood Park |
| State/Province | Massachusetts | Tennessee | Maryland | New Jersey |
| No. of Employees | - | 55 | 14 | 4,500 |
| Entity Type | Private | Public | Public | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Dan Malarek | Chief Executive Officer | Senior Management | 2023 | - |
| Dominique Schutz | Head - Corporate Management; Chief Financial Officer | Senior Management | 2021 | - |
| Winifred Lynn Swan | General Counsel; Chief Legal Officer | Senior Management | 2019 | - |
| Andrew Suchoff | Chief People Officer | Senior Management | 2021 | - |
| Todd Druley, M.D., Ph.D | Chief Medical Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer